🔴 McKesson is trading 6.3% down in after-hours trading after mixed fiscal Q2 results

McKesson is trading at $1,001.38, down 6.33%, after its fiscal Q2 report delivered an earnings and revenue beat alongside mixed segment details.

• Adjusted EPS was $11.68 and revenue was $111.0 billion, both above estimates.
• McKesson raised full-year adjusted EPS guidance to $45.60–$46.40.
• Medical-Surgical sales missed forecasts, and shares slipped after the results; available coverage does not establish that segment weakness fully explains the larger after-hours decline.